Kategori: Målrettet terapi

Målrettet behandling, Imatinib (Gleevec), Keytruda (pembrolizumab), Herceptin (trastuzumab)

marts 21, 2025
Enhertu. Deruxtecan

marts 21, 2025
Enzalutamid. Xtandi

marts 21, 2025
Trastuzumab. Trastuzumab (TDM1), Herceptin, Kadcyla

marts 21, 2025
Tyrosinkinasehæmmere. Crizotinib (Xalkori), Dasatinib (Sprycel), Erlotinib (Tarceva), (Gefitinib (Iressa)), Imatinib (Gleevec), (Lapatinib (Tykerb)), Nilotinib (Tasigna), Sorafenib (Nexavar), Sunitinib (Sutent)

marts 21, 2025